The patients had received anti-VEGF injections for indications such as retinal vein occlusion (RVO) in 21 patients (44.6%), choroidal neovascular membrane (CNVM) in 15 patients (31.9%), and pseudophakic cystoid macular edema (PCME) in 7 patients (14.89%). Here, VEGFA is linked to retinal vein occlusion.